AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable
Mobile Health App for Neuropathic Pain Management in MS (Human Study)
This study involved 56 adults with multiple sclerosis who were randomly assigned to either a mobile health app for neuropathic pain management or a standard care group. The intervention aimed to track pain and improve quality of life over an 8-week follow-up. No results have been posted yet.
- Tags
- #Other
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Other
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
This research could potentially provide insights into effective self-management strategies for individuals with MS, addressing a common and challenging symptom, neuropathic pain.
What this does not prove
Currently, there are no results available from this trial, and planned enrollment and endpoints are not considered findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 56 · actual
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Other
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Adults, ages from 18 Years
- Size of effect
- Not reported
- Secondary endpoints
- Change in Fatigue Measured by the Fatigue Severity Scale; Change in Insomnia Severity Measured by the Insomnia Severity Index; Change in Health-Promoting Lifestyle Behaviours Measured by the Health-Promoting Lifestyle Profile II; Change in Self-Management Measured by the Multiple Sclerosis Self-Management Scale
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (19)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years; sex All
speciesParticipants: people; ages from 18 Years; sex All
sample sizeEnrollment: 56 participants (actual)
sample size basisEnrollment: 56 participants (actual)
randomizedAllocation: Randomized
peer reviewedTrial registry record.
research categoriesHowever, existing mHealth applications often lack scientifically validated content, do not specifically address neuropathic pain, and have limited user-centered design features.\n\nThis study aims to develop a self-management-based mHealth application tailored for patients with MS experiencing neuropathic pain.
interventionInterventions: Mobile Health App for Neuropathic Pain Management in MS
comparatorArm 2 Name: Standard Care Group Intervention: No Intervention - Standard Care
primary endpointPrimary endpoints: Change in Neuropathic Pain Severity Measured by the Visual Analogue Scale; Change in Physical Health-Related Quality of Life Measured by the Multiple Sclerosis Quality of Life-54; Change in Mental Health-Related Quality of Life Measured by the Multiple Sclerosis Quality of Life-54
follow upFollow-up: Baseline and 8 weeks after intervention start
limitationsPlanned enrolment and endpoints are not findings.
mechanismsGrounded in Bandura's Social Cognitive Theory, the application will provide educational content, symptom tracking, goal-setting tools, and behavior change strategies covering topics such as nutrition, physical activity, sleep hygiene, stress management, and smoking cessation.
populationDefinite diagnosis of multiple sclerosis according to the 2017 McDonald criteria\n3.
secondary endpointsSecondary measures include changes in depression (BDI), insomnia (ISI), fatigue (FSS), and self-management (MSSM).
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
controlledArm types: Experimental; No intervention
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.